Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: May 26, 2022


✉ Email this page to a colleague

« Back to Dashboard

When do Makena Preservative Free patents expire, and what generic alternatives are available?

Makena Preservative Free is a drug marketed by Covis and is included in one NDA.

The generic ingredient in MAKENA PRESERVATIVE FREE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.

Drug patent expirations by year for MAKENA PRESERVATIVE FREE
Recent Clinical Trials for MAKENA PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

AMAG Pharmaceuticals, Inc.Phase 3
AMAG Pharmaceuticals, Inc.Phase 1

See all MAKENA PRESERVATIVE FREE clinical trials

US Patents and Regulatory Information for MAKENA PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis MAKENA PRESERVATIVE FREE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 021945-002 Feb 19, 2016 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for MAKENA PRESERVATIVE FREE

See the table below for patents covering MAKENA PRESERVATIVE FREE around the world.

Country Patent Number Title Estimated Expiration
South Korea 20070117543 PREFILLED NEEDLE ASSISTED JET INJECTOR See Plans and Pricing
China 101132820 Prefilled needle assisted jet injector See Plans and Pricing
Germany 69921704 See Plans and Pricing
Denmark 2953667 See Plans and Pricing
Austria 240756 See Plans and Pricing
Japan 5216328 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.